The impact of zoledronic acid therapy in
β
Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe
π
Article
π
2009
π
John Wiley and Sons
π
French
β 213 KB
π 2 views
## Abstract Bone metastases occur in 20β40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa